摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl N-[3-phenyl-1-oxo-2-propen-1-yl] glycinate | 40778-04-9

中文名称
——
中文别名
——
英文名称
methyl N-[3-phenyl-1-oxo-2-propen-1-yl] glycinate
英文别名
N-cinnamoyl-glycine methyl ether;N-Cinnamoyl-glycin-methylester;Cinnamoylglycinmethylester;Glycine,n-(1-oxo-3-phenyl-2-propen-1-yl)-, methyl ester;methyl 2-(3-phenylprop-2-enoylamino)acetate
methyl N-[3-phenyl-1-oxo-2-propen-1-yl] glycinate化学式
CAS
40778-04-9
化学式
C12H13NO3
mdl
——
分子量
219.24
InChiKey
XFAGPDNLMRNSRO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    16
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    55.4
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    methyl N-[3-phenyl-1-oxo-2-propen-1-yl] glycinate一水合肼三氯氧磷 作用下, 以 乙腈 为溶剂, 反应 1.0h, 生成 (E)-N-(5-Hydroxy-1H-pyrazol-4-yl)-3-phenyl-acrylamide
    参考文献:
    名称:
    Singh; Singh, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2000, vol. 39, # 9, p. 688 - 693
    摘要:
    DOI:
  • 作为产物:
    描述:
    甘氨酸甲酯盐酸盐肉桂酸1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺三乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 18.0h, 以90.2%的产率得到methyl N-[3-phenyl-1-oxo-2-propen-1-yl] glycinate
    参考文献:
    名称:
    Tyrosinase inhibitory effects and antioxidative activities of novel cinnamoyl amides with amino acid ester moiety
    摘要:
    Nine cinnamoyl amides with amino acid ester (CAAE) moiety were synthesized by the conjugation of the corresponding cinnamic acids (cinnamic acid, 4-hydroxy cinnamic acid, ferulic acid and caffeic acid) with amino acid esters, and their inhibitory effects on the activities of mushroom tyrosinase were investigated, using L-3,4-dihydroxyl-phenylalanine (L-DOPA) as the substrate. Among these CAAE amides, ethyl N-[3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl]-L-phenylalaninate (b(4)) showed the strongest inhibitory activity; the IC50 was 0.18 mu M. The IC50 values, inhibition types, inhibition mechanisms and kinetics of all these CAAE amides were evaluated. A structure-activity relationship (SAR) study found that the inhibitory effects were potentiated with the increasing length of hydrocarbon chains at the amino acid esters and also influenced by the substituents at the styrene groups. Furthermore, the hydroxyl radical scavenging and anti-lipid peroxidation activities of four CAAE derivatives were also investigated. Among these compounds, b(3) (ethyl N-[3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]-L-phenylalaninate) and b(4) exhibited potential antioxidant activities. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.foodchem.2012.03.021
点击查看最新优质反应信息

文献信息

  • Derivatives of L-proline, their preparation and their biological uses
    申请人:Inorgan SA Recherche & Developpement Pharmaceutiques, CAS
    公开号:US05212158A1
    公开(公告)日:1993-05-18
    The L-proline derivatives of the invention correspond to the Formula I: ##STR1## in which R.sub.1 corresponds to the Formula II: ##STR2## in which R is a carbonyl group, an acyl group --Y--CO-- or an oxy-acyl group --O--Y--CO--, Y being an alkyl or an alkenyl chain, Z being one or more hydrogen atoms, or one or more substituents chosen from among halogen atoms, CF.sub.3, alkyl or alkoxy groups and an alkylenedioxy group in the case of two neighbouring substituents, R.sub.2 is --NH.sub.2, --OH, or a derivative of these groups, A.sub.1 and A.sub.2 are amino acid residues and B.sub.1 and B.sub.2 represents a hydrogen atom or a methyl group, and the pharmacologically acceptable salts of these derivatives. These derivatives are useful particularly as the active principles of medicines possessing, in particular, a nootropic action.
    本发明的L-脯氨酸衍生物对应于公式I:##STR1## 其中R.sub.1对应于公式II:##STR2## 其中R是一个羰基基团,一个酰基--Y--CO--或一个氧酰基--O--Y--CO--,其中Y是一个烷基或烯基链,Z是一个或多个氢原子,或一个或多个从卤素原子,CF.sub.3,烷基或烷氧基和两个相邻取代基的烷二氧基基团中选择的取代基,R.sub.2是--NH.sub.2,--OH或这些基团的衍生物,A.sub.1和A.sub.2是氨基酸残基,B.sub.1和B.sub.2代表氢原子或甲基基团,以及这些衍生物的药学上可接受的盐。这些衍生物特别有用作具有神经保护作用的药物的活性成分。
  • Cinnamic acid derivative
    申请人:Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation)
    公开号:US06025444A1
    公开(公告)日:2000-02-15
    The invention provides a cinnamic acid derivative having a novel spacer introduced into cinnamic acid which is photodimerizable, a cinnamic acid-polysaccharide derivative photocurable with high sensitivity and efficiency obtainable by introducing the above cinnamic acid derivative into a host polysaccharide such as a glycosaminoglycan, and a photocrosslinked cinnamic acid-polysaccharide derivative obtainable by exposing the same cinnamic acid-polysaccharide derivative to ultraviolet light irradiation.
    本发明提供了一种在肉桂酸中引入新型间隔物的肉桂酸衍生物,该衍生物具有光二聚性;通过将上述肉桂酸衍生物引入宿主多糖(例如一种糖胺聚糖)中,可获得高灵敏度和高效性的肉桂酸-多糖衍生物光固化物;将同一肉桂酸-多糖衍生物暴露于紫外线照射下,可获得光交联的肉桂酸-多糖衍生物。
  • Cyrene: a bio-based solvent for the Mizoroki–Heck reaction of aryl iodides
    作者:Naya A. Stini、Petros L. Gkizis、Christoforos G. Kokotos
    DOI:10.1039/d2ob02012b
    日期:——
    widely used organic reactions. Cyrene has appeared to be an excellent alternative solvent for a number of organic reactions. In this work, the development of a new, greener and more economical protocol for the Mizoroki–Heck reaction is described, using Cyrene as the green solvent and Pd/C as the palladium catalyst source. A wide substrate scope for the coupling of aryl iodides with acrylamides, acrylates
    开发更绿色和更可持续的方法,以及使现有协议适应更环保的程序,已成为有机合成的关键。引入和利用更环保的溶剂是一种非常有前途的替代品,特别是当它们可以在已知和广泛使用的有机反应中替代有毒有机溶剂时。Cyrene 似乎是许多有机反应的极佳替代溶剂。在这项工作中,描述了一种新的、更环保、更经济的 Mizoroki–Heck 反应方案的开发,使用 Cyrene 作为绿色溶剂,Pd/C 作为钯催化剂源。展示了芳基碘与丙烯酰胺、丙烯酸酯、丙烯酸、丙烯腈和苯乙烯偶联的广泛底​​物范围。Cyrene 的可回收性和最终产品中钯的浸出进行了检查,以提高该协议的工业适用性。此外,还报道了天然产物哌洛汀 A 的合成。
  • Wei; Jiang; Zhang, Asian Journal of Chemistry, 2012, vol. 24, # 6, p. 2383 - 2388
    作者:Wei、Jiang、Zhang、Zhang、Guo
    DOI:——
    日期:——
  • Singh; Singh, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2000, vol. 39, # 9, p. 688 - 693
    作者:Singh、Singh
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物